·   Log in

Polymer-free drug eluting balloon technology ‘SeQuent Please’ launched in India: B Braun

Tagged with:
Thursday, December 3, 2009, 18:21 This news item was posted in medical devices category and has 0 Comments so far.

Polymerless tech cuts inflammation risk and re-occlusion following stenting


SeQuent Please, a polymer less drug eluting balloon technology for treating patients suffering from coronary artery diseases, has been launched in in India by B Braun India Pvt Ltd.

SeQuent Please drug eluting balloon technology does not use polymer in its design. This polymer less technology makes it free of any risk of inflammatory reactions or late stent thrombosis.

“The polymer less factor of ‘SeQuent Please’ benefits the patient with fewer side effects. Also, it reduces the need of administering clopidogrel which is an oral anti platelet agent to inhibit blood clots in coronary artery disease. As a result the technology becomes cost effective for the patient, stated Dr Martin Unverdorben, M.D., Ph.D., Associate Professor of Medicine.

SeQuent Please drug eluting balloon technology respects normal contours of the vessel without stent and provides uniform drug delivery at the target site for faster healing, B Braun said in a press statement.

Indian population shows a genetic disposition to cardiac blockages due to plaque formation. Approximately 1,50,000 coronary artery disease patients are intervened by cardiologists, out of which approximately 25-30 % show instent restenosis specially in small vessel disease, bifurcation lesions & Diabetics, according Dr. Upendra Kaul, executive director – Academics, Escorts Heart Institute And Research Centre.

SeQuent Please drug eluting balloon technology will be commercially available in the Indian market, said Aditya Banerjee, Dy Country Head, Aesculap Division, B Braun (I) Pvt Ltd, while announcing the release of the stent in Kochi, Kerala, southern India.

B. Braun Medical (I) Pvt. Ltd. is a manufacturing and marketing subsidiary of B. Braun Melsungen AG, Germany. B Braun – India came into existence in 1994, with headquarters in Mumbai.

B. Braun has a state of the art manufacturing plant at Mahindra world City, Chengalpet, near Chennai.

B Braun’s products can be broadly classified under: Equipments (Surgery, Intensive Care, Dialysis); Cardiology products; Surgical Instruments & Implants; Sutures; Single Use Disposables (Ward, Critical Care & Anesthesia) and Pharma Products (Plasma Volume Replacement, Anesthetics & Clinical Nutrition) etc.

Headquartered in Melsungen, Germany, B. Braun is  comprehensive Solution Provider specializing in therapeutic segments of healthcare.

Scroll down to comment on this story
You can leave a response, or trackback from your own site.

Leave a Reply